By Maeve Serino and Adam Brown Learn about what’s new and what’s coming soon in Smart Pens, automated insulin delivery, pumps, and more Diabetes technology moves fast,...

Sanofi’s insulin adjustment app to help people with type 2 diabetes optimize once-daily long-acting basal insulin is now available for Apple and Android devices

The FDA decision on Novo Nordisk’s basal insulin is based on positive safety and efficacy data of Tresiba versus other basal insulins

Implanted sensor with on-body transmitter lasts more than 12x longer than other CGMs; launch expected in Europe in late 2017

Limited US launch beginning in second half of this year, with full launch in early 2019; Dash PDM Handheld will be free with purchase of pods

Recruiting now! This major study will support FDA submission of Tandem’s t:slim X2 with Control-IQ and Dexcom G6 in people with type 1 ages 14 and up; includes automatic...

Experts and innovators from all corners gathered to share the latest in new technology and treatments for people with diabetes, focusing on improving CGM and outcomes...

One study seeks 920 adults with type 1 or type 2 diabetes not currently using a CGM; another is recruiting 400 children and teens with diabetes

After over a year of continued advocacy, Medicare will cover mobile CGM use and sharing (Dexcom G5 for now); Medicare’s policy will be updated by June 21 st , if not...

The smart insulin pen’s Android app is expected to launch later this year in the US; a Europe launch is expected in 2019. Plus, learn about four other smart pens/caps in...

An app uses blood sugar readings and other diabetes information to provide personalized guidance to workouts, along with exercise videos specifically for people with...

A study testing whether One Drop’s coaching app, along with Fitbit activity trackers, can help people with diabetes and prediabetes meet their goals

The world’s first all-diabetes professional cycling team is now sponsored by Dexcom; diabetes research studies on CGM and exercise will start this year: What is the...

The diaTribe Foundation and TCOYD hosted a panel discussion at the ADA 78 th Scientific Sessions in Orlando, Florida; read about insights on how to improve diabetes care

Acclaimed author James S. Hirsch on his encounter with a broken healthcare system while trying to obtain FreeStyle Libre for his teenage son

A positive 8-0 vote at the FDA paves the way for first implanted CGM to come to the US; read what patient advocates and healthcare providers like about Eversense!

Approved for adults, the latest FreeStyle Libre will launch in US pharmacies in coming months

App allows FreeStyle Libre sensor users to monitor blood sugar on their smartphone without a separate reader. Tools also available for sharing glucose data with...

Toujeo Max SoloStar will launch later this year in the US. It holds 900 units of insulin and can dose up to 160 units in one injection, meaning fewer refills and...

Learn more about DiabetesMine D-Data highlights, implantable CGM Eversense used in adolescents, and Sugar.IQ real-world data